Tranexamic Acid
Back to searchMolecule Structure
Scientific Name
Tranexamic Acid
Description of the Drug
Tranexamic acid is an antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00302
http://www.drugbank.ca/drugs/DB00302
Brand Name(s)
Cyklo-f heavy period relief, Cyklokapron, Exacyl, Lysteda, Menstralite, Tranexamic acid
Company Owner(s)
American Regent Inc, Xgen Pharmaceuticals Djb Inc, Emcure Pharmaceuticals Ltd, Zydus Pharmaceuticals Usa Inc, Akorn Operating Co Llc, Micro Labs Ltd, Fresenius Kabi Usa Llc, Ani Pharmaceuticals Inc, Virtus Pharmaceuticals Llc, Caplin Steriles Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Plasminogen | SINGLE PROTEIN | INHIBITOR | CHEMBL1801 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16974 | ||
| Human Metabolome Database | HMDB0014447 | ||
| DrugBank | DB00302 | ||
| PubChem: Thomson Pharma | 15321700 | ||
| Mcule | MCULE-6087008336 | ||
| LINCS | LSM-5332 | ||
| Nikkaji | J3.664A | ||
| PDBe | AMH | ||
| BindingDB | 50428067 | ||
| DrugCentral | 2713 | ||
| ChemicalBook | CB2948513 | CB1117189 | CB54848494 |
| Guide to Pharmacology | 6573 | ||
| rxnorm | LYSTEDA | CYKLOKAPRON | TRANEXAMIC ACID |
| ChEBI | 48669 | ||
| ZINC | ZINC000100071256 |
